Adherium Launches the Hailie Global Brand to Connect People with Asthma and COPD to Better Care

Adherium, an award-winning digital health company that improves medication adherence, patient outcomes and engagement, today announced the launch of the Hailie™ global brand to connect people with asthma and COPD to better care. The launch is a rebrand of the existing Smartinhaler™ brand, and includes the free Hailie™ app, an asthma and COPD tracking solution available on both iOS and Android, ultimately setting the stage for availability of Hailie™ sensors to consumers in the U.S.

The Hailie™ brand supports the Company’s acceleration to meet commercial demand, as patients seek the benefits of connected technology to manage their health.

“With more and more patients leveraging technology for not just tracking fitness but overall health, we want to give them a personified brand like Hailie that they can identify with,” said Vik Panda, Adherium’s VP of Marketing. “Hailie is your asthma and COPD sidekick, always there to support you and help you manage your condition.”

Adherium believes health technology should be easy to use and it strives to make the Hailie™ solution effortless for anybody managing chronic respiratory symptoms, and it has the clinical history to support this.

“We’re extremely excited to announce the Hailie brand. It encompasses the world’s most clinically proven asthma and COPD medication adherence solution and represents an evolution of our business,” said Arik Anderson, CEO of Adherium. “Our technology, which is supported by 15 years of research and development, will soon be available directly to patients for the first time ever in the U.S.”

Adherium’s technology has garnered a wide body of clinical evidence, having been featured in 72 peerreviewed journals to date. Additionally, more than 100,000 inhaler sensors have been distributed globally.

Adherium’s Hailie™ solution is designed to help patients achieve better adherence. It does this by tracking medication use and reminding the user with helpful nudges when it’s time to take doses. People who live with asthma or COPD gain the tools to better manage their condition with their physician, empowering them to take control of their health.

As part of the comprehensive Hailie™ solution, Adherium is also launching a portal for healthcare professionals and clinicians (go.hailie.com) that uses Bluetooth® wireless technology to provide data collection and reporting from Hailie™ sensors. This platform will support engagement between healthcare professionals and patients by enabling sharing and monitoring of patient inhaler usage.


Disclaimer

The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkine.com.au and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). The information on this website has been prepared from a wide variety of sources, which Kalkine Pty Ltd, to the best of its knowledge and belief, considers accurate. You should make your own enquiries about any investments and we strongly suggest you seek advice before acting upon any recommendation. Kalkine Pty Ltd has made every effort to ensure the reliability of information contained in its newsletters and websites. All information represents our views at the date of publication and may change without notice. To the extent permitted by law, Kalkine Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services. There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. The link to our Terms & Conditions has been provided please go through them and also have a read of the Financial Services Guide. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

w

Connecting to %s